ID SK-N-MC-IXC AC CVCL_1398 SY MC-IXC; MCIXC DR BTO; BTO_0005372 DR CLO; CLO_0007615 DR EFO; EFO_0002230 DR ArrayExpress; E-MTAB-38 DR ArrayExpress; E-MTAB-783 DR ATCC; CRL-2270 DR BioGRID_ORCS_Cell_line; 939 DR BioSample; SAMN03472918 DR cancercelllines; CVCL_1398 DR Cell_Model_Passport; SIDM01246 DR ChEMBL-Cells; CHEMBL3308758 DR ChEMBL-Targets; CHEMBL1075495 DR Cosmic; 688068 DR Cosmic; 908118 DR Cosmic-CLP; 908118 DR DepMap; ACH-002160 DR GDSC; 908118 DR GEO; GSM1670077 DR IGRhCellID; MCIXC DR LINCS_LDP; LCL-1967 DR PharmacoDB; MCIXC_886_2019 DR PRIDE; PXD030304 DR Progenetix; CVCL_1398 DR PubChem_Cell_line; CVCL_1398 DR TOKU-E; 4055 DR Wikidata; Q54954480 RX PubMed=4748425; RX PubMed=15892104; RX PubMed=20164919; RX PubMed=20215515; RX PubMed=25877200; RX PubMed=27397505; RX PubMed=30894373; RX PubMed=30971826; RX PubMed=35839778; WW Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-mc-ixc-human-neuroblastoma-cell-line CC Problematic cell line: Misclassified. Parent cell line (SK-N-MC) was originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor. CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC From: Memorial Sloan Kettering Cancer Center; New York; USA. CC Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2010-067. CC Population: Caucasian. CC Microsatellite instability: Instable (MSI-low) (Sanger). CC Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.170_572del; Zygosity=Unspecified (from parent cell line). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; CRISPR screening. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Variations; Array-based CGH. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=0%; European, North=74.37%; European, South=25.63% (PubMed=30894373). CC Derived from site: Metastatic; Orbital region; UBERON=UBERON_0004088. ST Source(s): ATCC=CRL-2270; Cosmic-CLP=908118; PubMed=25877200 ST Amelogenin: X ST CSF1PO: 10 ST D13S317: 11 ST D16S539: 12 ST D18S51: 13,14,15 ST D19S433: 13,15.2 ST D21S11: 30,31.2 ST D2S1338: 17,21 ST D3S1358: 15 ST D5S818: 11 ST D7S820: 8 ST D8S1179: 10 ST FGA: 21,25 ST Penta D: 9,13 ST Penta E: 16,18 ST TH01: 9.3 ST TPOX: 9,11 ST vWA: 17,18 DI NCIt; C7542; Askin tumor DI ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0530 ! SK-N-MC SX Female AG 12Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 41 CH CVCL_B0FD ! SK-N-MC-IXC/VCR // RX PubMed=4748425; RA Biedler, June Lee RA Helson, Lawrence RA Spengler, Barbara A. RT "Morphology and growth, tumorigenicity, and cytogenetics of human RT neuroblastoma cells in continuous culture."; RL Cancer Res. 33:2643-2652(1973). // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=15892104; DOI=10.1002/gcc.20198; RA Mosse, Yael P. RA Greshock, Joel RA Margolin, Adam A. RA Naylor, Tara RA Cole, Kristina A. RA Khazi, Deepa RA Hii, George RA Winter, Cynthia RA Shahzad, Syed RA Asziz, Muhammad Usman RA Biegel, Jaclyn A. RA Weber, Barbara L. RA Maris, John Matthew RT "High-resolution detection and mapping of genomic DNA alterations in RT neuroblastoma."; RL Genes Chromosomes Cancer 43:390-403(2005). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662; RA Rothenberg, S. Michael RA Mohapatra, Gayatry RA Rivera, Miguel N. RA Winokur, Daniel RA Greninger, Patricia RA Nitta, Mai RA Sadow, Peter M. RA Sooriyakumar, Gaya RA Brannigan, Brian W. RA Ulman, Matthew J. RA Perera, Rushika M. RA Wang, Rui RA Tam, Angela RA Ma, Xiao-Jun RA Erlander, Mark RA Sgroi, Dennis C. RA Rocco, James W. RA Lingen, Mark W. RA Cohen, Ezra E.W. RA Louis, David Neil RA Settleman, Jeffrey RA Haber, Daniel Arie RT "A genome-wide screen for microdeletions reveals disruption of RT polarity complex genes in diverse human cancers."; RL Cancer Res. 70:2158-2164(2010). // RX PubMed=30971826; DOI=10.1038/s41586-019-1103-9; RA Behan, Fiona M. RA Iorio, Francesco RA Picco, Gabriele RA Goncalves, Emanuel RA Beaver, Charlotte M. RA Migliardi, Giorgia RA Santos, Rita RA Rao, Yanhua RA Sassi, Francesco RA Pinnelli, Marika RA Ansari, Rizwan RA Harper, Sarah RA Jackson, David Adam RA McRae, Rebecca RA Pooley, Rachel RA Wilkinson, Piers RA van der Meer, Dieudonne J. RA Dow, David RA Buser-Doepner, Carolyn A. RA Bertotti, Andrea RA Trusolino, Livio RA Stronach, Euan Alexander RA Saez-Rodriguez, Julio RA Yusa, Kosuke RA Garnett, Mathew J. RT "Prioritization of cancer therapeutic targets using CRISPR-Cas9 RT screens."; RL Nature 568:511-516(2019). //